https://www.gosh.nhs.uk/our-people/staff-z/paul-brogan/
Paul Brogan
Dr Paul Brogan works in the department of Rheumatology at Great Ormond Street Hospital (GOSH) and is section head for Infection, Inflammation and Rheumatology in the UCL Institute of Child Health (ICH).
He has developed a successful clinical and academic programme of work dedicated to the developing field of paediatric vasculitis and autoinflammatory diseases, in concert with a world-leading clinical service for these rare diseases as Chair of the Vasculitis Consortium and Clinical Lead for Autoinflammatory Disease at GOSH.
Qualifications
Dr Brogan's research contributions, combined with clinical developments in his field, are internationally recognised. His clinical background spanning both paediatric nephrology and rheumatology, combined with a PhD studying the pathogenesis of systemic vasculitis in children, provides a unique clinician scientist perspective in this area.
Research Interests
Dr Brogan has established a team of researchers that are producing publications of international repute and this work ties in closely with the Clinical Paediatric Rheumatology department at GOSH. This has been achieved through strong collaborations internationally (eg the European Vasculitis Study Group and the Pediatric Rheumatology International Trials Organisation), nationally (particularly with the MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group) and within the ICH (particularly with the National Amyloidosis Centre).
He is a major grant holder and has published many scientific articles, three textbooks and 10 major textbook chapters. He gives invited lectures and presentations at national and international scientific meetings. These include major international meetings in the fields of vasculitis, rheumatology, immunology, nephrology and paediatrics.
Dr Brogan plays a significant enabling role furthering paediatric rheumatology translational research in the MCRN/ARUK Paediatric Rheumatology Clinical Studies Group. This is a crucial strategic means of driving clinical trials and translational research for paediatric rheumatology (including vasculitis) in the UK.